Fasting improves oral bioavailability of mitragynine in healthy female Beagles
American Journal of Veterinary Research · 2026
DOI: 10.2460/ajvr.25.07.0235 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Abigail Ortiz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL. Hauptthemen laut MEDLINE: Secologanin Tryptamine Alkaloids, Fasting, Plant Extracts, Mitragyna. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the pharmacokinetic profile and safety of an encapsulated kratom extract when administered orally to fed and fasted healthy female Beagles.
Methods
The study was conducted over a 24-hour period in June 2023. Dogs were randomly assigned to 2 groups (4 dogs each). All dogs received 8 mg (targeted mitragynine dose of 0.55 to 0.68 mg/kg) of a formulated kratom extract per capsule (45% mitragynine, weight-for-weight kratom extract). One group was administered the capsule with food and the other after fasting. Blood sampling was performed at fixed time points over 24 hours. Plasma concentrations of mitragynine and its metabolites were measured using UPLC-MS-MS. Safety assessment included clinical monitoring of vital signs, and a CBC and biochemical analysis before and 24 hours after dosing.
Results
Peak plasma concentration of mitragynine in the fasted group was 55.2 ± 6.1 ng/mL and occurred at 1.3 ± 0.3 hours postdose. In contrast, the peak plasma concentration of mitragynine in the fed group was 25.6 ± 6.7 ng/mL and occurred at 7.5 ± 2.1 hours postdose. Relative bioavailability with food was 30% lower than in the fasted group. Administration of a single oral dose of an encapsulated kratom extract was well tolerated, with no adverse effects.
Conclusions
Rapid absorption and greater systemic exposure of mitragynine were achieved when encapsulated kratom extract was administered on an empty stomach. Clinical Relevance Greater pharmacologic potential should be expected when encapsulated kratom extract is administered to fasted animals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL.
- Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL.
- Department of Comparative, Diagnostic and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL.
- Translational Drug Development Core, Clinical and Translational Science Institute, University of Florida, Gainesville, FL.
- Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL.
ORCID-Profile: Elizabeth A Maxwell, Abhisheak Sharma
Zitieren
APA
Ortiz, A., Maxwell, E. A., Kuntz, M., Gour, A., Portela, D. A., Miscioscia, E., Bertran, J., Grewal, M., McCurdy, C. R., & Sharma, A. (2026). Fasting improves oral bioavailability of mitragynine in healthy female Beagles. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.07.0235
Vancouver
Ortiz A, Maxwell EA, Kuntz M, Gour A, Portela DA, Miscioscia E, et al. Fasting improves oral bioavailability of mitragynine in healthy female Beagles. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.25.07.0235
BibTeX
@article{Ortiz2026,
author = {Ortiz, Abigail and Maxwell, Elizabeth A and Kuntz, Michelle and Gour, Abhishek and Portela, Diego A and Miscioscia, Erin and Bertran, Judith and Grewal, Manraj and McCurdy, Christopher R and Sharma, Abhisheak},
title = {Fasting improves oral bioavailability of mitragynine in healthy female Beagles},
journal = {American Journal of Veterinary Research},
year = {2026},
doi = {10.2460/ajvr.25.07.0235}
}
EUVIMED